Is CAG a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Conagra Brands (CAG) rests on Frozen and snacks as the growth engine: Conagra has concentrated investment in frozen meals and snacking, categories where it holds strong brands and better volume trends. The bear case rests on the biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins; management already guides fiscal 2027 organic sales down 1% to 3%. Analysts covering it publish targets from $11.00 to $16.00 against a $14.47 price, so even the professionals disagree by 36% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Conagra Brands is one of the largest packaged-food companies in North America, with a portfolio spanning frozen meals (Healthy Choice, Marie Callender's, Banquet, Birds Eye), snacks (Slim Jim, Angie's Boomchickapop, Duke's) and grocery staples (Hunt's, Chef Boyardee, Reddi-wip, Orville Redenbacher's). The company sells primarily through US grocery, mass and club retailers, and it has leaned its strategy toward higher-growth frozen and snacking categories while managing legacy shelf-stable brands. The investment picture is that of a mature consumer-staples business facing sluggish demand. Net sales slid from about $12.3 billion in fiscal 2023 to about $11.6 billion in fiscal 2025 and about $11.3 billion in fiscal 2026 (ended May 2026), and large impairment charges turned fiscal 2026 into a GAAP net loss of about $1.9 billion even though adjusted EPS was roughly $1.70. New CEO John Brase then reset expectations: fiscal 2027 guidance calls for organic net sales down 1% to 3% and adjusted EPS of $1.40 to $1.50, and the quarterly dividend was cut from $0.35 to $0.175 beginning with the July 30, 2026 ex-dividend date. The first quarter of fiscal 2027 (ended August 2026) was better than feared, with net sales of about $2.60 billion versus $2.63 billion a year earlier and adjusted EPS of $0.41 against a $0.28 consensus, but free cash flow in the quarter was negative and net leverage stood near 4.0 times. The stock is down about 17% year to date and 22% over the past year.
The bull case: what would have to be true for $16.00
The most optimistic published target on CAG is $16.00, +10.6% from the $14.47 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Frozen and snacks as the growth engine
Conagra has concentrated investment in frozen meals and snacking, categories where it holds strong brands and better volume trends. In its third quarter of fiscal 2026 the company reported around 2.4 percent organic net sales growth, with frozen and snacks cited as the standout areas, but the total business has since slipped back, with first-quarter fiscal 2027 net sales down about 1.4% and second-quarter organic sales guided to roughly -2%. Continued share gains in frozen and snacks are central to stabilizing the overall top line.
2. Margin recovery and cost management
Operating margin was about 11.5% in the first quarter of fiscal 2027, but management expects the second quarter to fall to the high single digits as inflation runs toward the higher end of a 5% to 6% range. Cost programs described as Project Catalyst and portfolio simplification are meant to rebuild margin, and the ability to offset commodity and packaging costs through pricing and productivity is the key swing factor for earnings.
3. New leadership and strategy reset
John Brase, a former J.M. Smucker president and COO and a longtime Procter and Gamble executive, became CEO on June 1, 2026, succeeding Sean Connolly. The fresh look at capital allocation that a leadership change tends to bring arrived quickly: within weeks the company lowered fiscal 2027 earnings guidance, halved the dividend and took a more conservative stance on leverage.
4. Dividend and balance-sheet debt
CAG now pays $0.175 per quarter, or $0.70 a year, down from $1.40, which works out to a yield near 4.9% at the October 2026 price and roughly half of fiscal 2027 adjusted EPS guidance, versus close to all of it at the old rate. Debt of about $7.8 billion against $372 million of cash left net leverage near 4.0 times at the end of August, above the company's 3 times target, so the freed-up cash is expected to go toward paying debt down.
The bear case: what would have to be true for $11.00
The most pessimistic published target is $11.00, -24.0% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Conagra Brands is worth if the risks below bite instead of the drivers above.
The biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins; management already guides fiscal 2027 organic sales down 1% to 3%. The dividend cut removed one overhang but also removed much of the income case for existing shareholders, and the remaining yield still depends on cash generation that was negative in the first quarter of fiscal 2027. High leverage (about 4.0 times, with roughly $360 million of annual interest) limits flexibility if earnings weaken further, and the roughly $1.9 billion of fiscal 2026 impairments show that brand values can be written down sharply. Input-cost inflation toward the upper end of a 5% to 6% range, retailer promotional demands and any brand missteps could all weigh on results. Execution under a new CEO adds uncertainty until a clear strategy is demonstrated.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CAG already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on CAG
15 analysts cover CAG, with an average target of $13.74 (-5.0% against $14.47) and a split of 1 buy, 10 hold, 5 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the CAG forecast and price target page.
How is CAG valued? (as of October 2026)
Snapshot for CAG as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (FY2026, ended May 2026): ~$11.3B; Q1 FY2027 net sales ~$2.60B, down ~1.4%
- Net income (FY2026): ~-$1.9B GAAP loss after impairments; adjusted EPS ~$1.70
- Q1 FY2027 adjusted EPS: $0.41 vs $0.28 consensus
- Adjusted EPS guidance (FY2027): ~$1.40 to $1.50
- Dividend: $0.175 quarterly ($0.70 annual), cut from $0.35; yield ~4.9%
- Forward P/E: ~9.4x (no meaningful trailing P/E after the GAAP loss)
- Market cap: ~$6.8B (shares ~$14.32)
- Debt: ~$7.8B against ~$372M cash; net leverage ~4.0x
Conagra trades at about 9 times forward earnings and roughly book value, low for a branded-food company and a reflection of shrinking sales, roughly 4 times leverage and the GAAP losses from fiscal 2026 impairments. The halved dividend now consumes about half of guided adjusted EPS rather than nearly all of it. The next report, for the second quarter of fiscal 2027, is expected around December 18, 2026, with consensus EPS of about $0.34 on $2.92 billion of revenue.
How do you decide if CAG is a buy?
Rather than asking whether CAG is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CAG indirectly through an index or sector ETF before adding more.
What would change your mind on CAG
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Frozen and snacks as the growth engine stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: the biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins; management already guides fiscal 2027 organic sales down 1% to 3% fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the CAG stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CAG against your real portfolio and see your actual exposure before deciding.
Investing in Conagra Brands with AI
Connect the broker you already use and ask Walnut's AI how CAG fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is CAG a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Frozen and snacks as the growth engine, with revenue (fy2026, ended may 2026) at ~$11.3B; Q1 FY2027 net sales ~$2.60B, down ~1.4%. The bear case rests on the biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins; management already guides fiscal 2027 organic sales down 1% to 3%. Analysts covering it are spread from $11.00 to $16.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell CAG?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins; management already guides fiscal 2027 organic sales down 1% to 3%. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $11.00, -24.0% from the $14.47 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for CAG?
+
Frozen and snacks as the growth engine. Conagra has concentrated investment in frozen meals and snacking, categories where it holds strong brands and better volume trends. The most optimistic analyst target on CAG is $16.00, +10.6% from the $14.47 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for CAG?
+
The biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins; management already guides fiscal 2027 organic sales down 1% to 3%. The dividend cut removed one overhang but also removed much of the income case for existing shareholders, and the remaining yield still depends on cash generation that was negative in the first quarter of fiscal 2027. High leverage (about 4.0 times, with roughly $360 million of annual interest) limits flexibility if earnings weaken further, and the roughly $1.9 billion of fiscal 2026 impairments show that brand values can be written down sharply. Input-cost inflation toward the upper end of a 5% to 6% range, retailer promotional demands and any brand missteps could all weigh on results. Execution under a new CEO adds uncertainty until a clear strategy is demonstrated. The most pessimistic published target is $11.00, -24.0% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Conagra Brands do?
+
Conagra Brands is one of the largest packaged-food companies in North America, with a portfolio spanning frozen meals (Healthy Choice, Marie Callender's, Banquet, Birds Eye), snack
What would have to change for CAG to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Frozen and snacks as the growth engine) stalling in the reported numbers rather than in the narrative, the risk above (the biggest risk is prolonged volume softness in packaged food as consumers trade down to private label or shift spending, which would keep pressure on sales and margins; management already guides fiscal 2027 organic sales down 1% to 3%) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Conagra Brands do?
+
Conagra Brands is a US packaged-food company that makes and sells frozen meals, snacks and grocery staples. Its brands include Healthy Choice, Marie Callender's, Banquet, Birds Eye, Slim Jim, Hunt's, Chef Boyardee and Reddi-wip, sold mainly through grocery, mass and club retailers.
What is CAG's dividend yield?
+
After the 2026 cut, Conagra pays $0.175 per quarter, or $0.70 a year. At the October 16, 2026 price of about $14.32 that is a yield of roughly 4.9%, down from the high single digits to low double digits the old $1.40 annual rate implied earlier in the year.
Is the Conagra dividend safe?
+
The old dividend was not: Conagra halved its quarterly payout from $0.35 to $0.175 beginning with the July 30, 2026 ex-dividend date, after the old rate had grown to consume nearly all of guided adjusted EPS. The new $0.70 annual rate is about half of fiscal 2027 adjusted EPS guidance of $1.40 to $1.50, a more comfortable ratio, though first-quarter free cash flow was negative and leverage is near 4 times, so cash generation still matters.
Walnut is informational, not investment advice, and gives no verdict on CAG. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.